Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

December-14-11

CRR to Refile Lawsuit Against FDA and HHS Secretary Sebelius

Yesterday US District Judge Edward Korman ruled that he would allow the Center for Reproductive Rights (CRR) to refile a case against the FDA for "imposing unnecessary age restrictions on emergency contraceptives, and seek immediate relief to allow broader access to available drugs." Judge Korman will also permit CRR to add Health and Human Services Secretary Kathleen Sebelius as a defendant after she overruled the FDA's decision to lift the age limit for emergency contraception and permit the over-the-counter sale of the Plan B One-Step last week and instructed the FDA Commissioner to deny the request for over-the-counter sales with a prescription for Plan B One-Step.

Nancy Northup, president and CEO of CRR, stated, "We intend to take every legal step necessary to hold the FDA and this administration accountable for its extraordinary actions to block women from safe, effective emergency contraception. It has been ten years of battling to bring emergency contraception out from behind the pharmacy counter. The FDA cannot simply continue moving the goal posts down the field for women's reproductive healthcare."

Judge Korman nevertheless denied the Center for Reproductive Right's (CRR) request to hold the Food and Drug Administration (FDA) in contempt of court for delaying a decision on nonprescription drug sales for Plan B. He indicated that the request was "moot" given the FDA recently issued its decision regarding Plan B.

Currently Plan B is available to women 17 years and older without a prescription. But because of the restriction that females under 17 must have a prescription to buy Plan B, it is only available for all women behind the counter of a pharmacy. Levonorgestrel, sold under the brand name Plan B, is a form of emergency contraception that must be taken within 72 hours of sexual activity.

Media Resources: National Partnership for Women and Families 12/14/11; CRR Statement 12/13/11; Feminist Daily Newswire 11/16/10


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

7/28/2014 Study: Texas Laws Have Significantly Reduced Access to Abortion - The Texas Policy Evaluation Project (TxPEP) released a study in the medical journal Contraception finding that access to abortion has been significantly reduced since the state enacted it omnibus anti-abortion law HB2. The study, released last week, details the striking impact that HB2 has had on abortion access in Texas. . . .
 
7/28/2014 Wisconsin Will Not Enforce Contraceptive Coverage Law If Employers Raise Religious Objections - Citing the recent United States Supreme Court ruling in Burwell v. . . .
 
7/25/2014 Senate Foreign Relations Committee Passes Disabilities Treaty - By a vote of 12 to 6, the Senate Foreign Relations Committee agreed to recommend ratification of the United Nations Convention on the Rights of Persons with Disabilities to the full US Senate. "One hundred forty six nations and the European Union have ratified the Disabilities Treaty, but it will require American leadership to ensure the treaty's protections become a reality," said Senator Bob Menendez (D-NJ), Chair of the Foreign Relations Committee. . . .